The Week Ahead: COS...
Health Care: Drugs
Vical Incorporated (VICL: NASDAQ)
$3.50 -0.08 | -2.23%
05/24/13 - 04:00 PM ET
Portfolios with VICL
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor22 Biopharma Stocks With Br...
- UserO4 Investing
- ContributorStocks With Big Insider Buy...
- Contributor10 Best-Performing Stocks U...
- ContributorRelative Strength Stocks 09...
- ContributorCancer Drug Stocks to Trade...
- ContributorBreakout Stocks Of The Week...
- ContributorDollar Store
Latest VICL Headlines from TheStreet
- Vical Appoints Richard M. Beleson And Stephen A. Sherwin, M.D., To Board Of Directors 05.23.13 | 04:05 pm
- Interesting VICL Put And Call For July 05.20.13 | 03:05 pm
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma 05.17.13 | 07:05 am
- Short Interest In Vical Moves 21.2% Higher 05.10.13 | 03:05 pm
- Vical Reports First Quarter 2013 Financial Results And Progress In Key Development Programs 05.09.13 | 06:05 am
- Vical To Present At May Investor Conferences 05.07.13 | 06:05 am
- Vaxfectin(R) Enhances Preclinical Immune Responses To Baxter's Cell Culture-Derived Influenza Vaccines 05.06.13 | 06:05 am
- Vical Announces News Release And Conference Call Schedule For First Quarter 2013 Financial Results 05.02.13 | 06:05 am
- Vical CEO To Participate In Cancer Immunotherapy Panel At BIO International Convention 04.22.13 | 06:04 am
- 6 Stocks Under $10 Spiking Higher 04.04.13 | 03:04 pm
Press Releases for VICL
- MERIAL Receives Full License Approval For ONCEPT(TM) Canine Melanoma Vaccine - PR Newswire 02.16.10 | 08:02 am
Partner Headlines for VICL
- Vical and Bristol-Myers Ink Deal - Analyst Blog - NASDAQ 09.17.12 | 07:09 pm
- Abbott-Astellas Collaborate - Analyst Blog - NASDAQ 09.13.12 | 10:09 pm
- Abbott-Astellas Collaborate - Analyst Blog - Zacks 09.13.12 | 06:09 pm
- 3 Vaccine Companies With Upcoming Catalysts - Seeking Alpha 09.09.12 | 08:09 am
- 3 Speculative Biotechs Worth Watching - Seeking Alpha 07.08.12 | 08:07 am
- Vical Back On The Move - Seeking Alpha 11.04.11 | 06:11 pm
- Vical: Making Progress In The Area Of HSV-2 Vaccines - Seeking Alpha 08.26.11 | 10:08 pm
- 5 Healthcare Stocks of Interest This Week - Seeking Alpha 07.15.11 | 06:07 pm
- Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward - Seeking Alpha 03.29.11 | 08:03 am
- Ipilimumab Approval Highlights Active Immunotherapy Renaissance - Seeking Alpha 03.27.11 | 08:03 am
